RxSight Inc.
Organization details
- Legal name
- RxSight Inc.
- Former names
- Calhoun Vision Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3851 — Ophthalmic Goods
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Aliso Viejo
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- RXST
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001111485
- EIN
- 94-3268801
Board of directors
-
Aziz Mottiwala · Director · President and CEOSince 2026
-
Bakker Juliet Tammenoms · DirectorSince 2023
-
Jesse Anderson Corley · DirectorSince 2023
-
Julie Andrews · DirectorSince 2023
-
Raymond W. Cohen · DirectorSince 2025
-
Robert J. Palmisano · DirectorSince 2023
-
Robert Keith Warner · DirectorSince 2023
-
Ronald M. Kurtz M.D. · Director · President & CEOSince 2023
-
Shweta Maniar · DirectorSince 2023
-
Tamara Fountain · DirectorSince 2023
-
William J. Link Ph.D. · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 16, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
100.0%
-
100.0%
-
100.0%
Board connections
6 of this board's directors also sit on 8 other boards. 8 are in the same sector.
-
AEON Biopharma Inc. Same sectorvia Robert J. Palmisano
-
CeriBell Inc. Same sectorvia Bakker Juliet Tammenoms
-
InspireMD Inc. Same sectorvia Raymond W. Cohen
-
Kestra Medical Technologies Ltd. Same sectorvia Raymond W. Cohen
-
LENSAR Inc. Same sectorvia William J. Link Ph.D.
-
Orthofix Medical Inc. Same sectorvia Shweta Maniar
-
Sight Sciences Inc. Same sectorvia Tamara Fountain
-
Tarsus Pharmaceuticals Inc. Same sectorvia William J. Link Ph.D.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $117,951
- 4 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Weinberg Eric Officer (See remarks) | Option exercise | +35,168 | $4.34 | $152,629 |
| Sep 2, 2026 | Goldshleger Ilya Officer (Chief Operating Officer) | Open-market sale | −2,041 | $6.96 | $14,205 |
| Sep 2, 2026 | Ronald M. Kurtz M.D. Officer (Chief Medical Officer) | Open-market sale | −5,100 | $6.96 | $35,496 |
| Sep 2, 2026 | Weinberg Eric Officer (See remarks) | Open-market sale | −2,041 | $6.96 | $14,205 |
| Sep 2, 2026 | Wilterding Mark Officer (Chief Financial Officer) | Open-market sale | −7,765 | $6.96 | $54,044 |
| Aug 31, 2026 | Goldshleger Ilya Officer (Chief Operating Officer) | Option exercise | +5,370 | — | — |
| Aug 31, 2026 | Ronald M. Kurtz M.D. Officer (Chief Medical Officer) | Option exercise | +13,425 | — | — |
| Aug 31, 2026 | Weinberg Eric Officer (See remarks) | Option exercise | +5,370 | — | — |
| Aug 31, 2026 | Wilterding Mark Officer (Chief Financial Officer) | Option exercise | +20,441 | — | — |
| Jun 17, 2026 | Robert Keith Warner Director | Grant or award | +37,037 | — | — |
| Jun 17, 2026 | Robert J. Palmisano Director | Grant or award | +37,037 | — | — |
| Jun 17, 2026 | Shweta Maniar Director | Grant or award | +37,037 | — | — |
| Jun 17, 2026 | Tamara Fountain Director | Grant or award | +37,037 | — | — |
| Jun 17, 2026 | William J. Link Ph.D. Director | Grant or award | +37,037 | — | — |
| Jun 17, 2026 | Jesse Anderson Corley Director | Grant or award | +37,037 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about RxSight Inc.
Who is the CEO of RxSight Inc.?
Aziz Mottiwala has been RxSight Inc.'s President and CEO since July 2026.
How many directors are on RxSight Inc.'s board?
RxSight Inc.'s board has 11 directors: Aziz Mottiwala, Bakker Juliet Tammenoms, Jesse Anderson Corley, Julie Andrews, Raymond W. Cohen, Robert J. Palmisano, Robert Keith Warner, Ronald M. Kurtz M.D., Shweta Maniar, Tamara Fountain and 1 other.
Are RxSight Inc. insiders buying or selling shares?
Over the last 12 months, RxSight Inc. insiders made no open-market purchases and sold $117,951 of shares in 4 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="rxsight-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.